204 related articles for article (PubMed ID: 15861006)
1. Ankyrin-based cardiac arrhythmias: a new class of channelopathies due to loss of cellular targeting.
Mohler PJ; Bennett V
Curr Opin Cardiol; 2005 May; 20(3):189-93. PubMed ID: 15861006
[TBL] [Abstract][Full Text] [Related]
2. Cardiac ankyrins: Essential components for development and maintenance of excitable membrane domains in heart.
Cunha SR; Mohler PJ
Cardiovasc Res; 2006 Jul; 71(1):22-9. PubMed ID: 16650839
[TBL] [Abstract][Full Text] [Related]
3. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death.
Mohler PJ; Schott JJ; Gramolini AO; Dilly KW; Guatimosim S; duBell WH; Song LS; Haurogné K; Kyndt F; Ali ME; Rogers TB; Lederer WJ; Escande D; Le Marec H; Bennett V
Nature; 2003 Feb; 421(6923):634-9. PubMed ID: 12571597
[TBL] [Abstract][Full Text] [Related]
4. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function.
Mohler PJ; Splawski I; Napolitano C; Bottelli G; Sharpe L; Timothy K; Priori SG; Keating MT; Bennett V
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9137-42. PubMed ID: 15178757
[TBL] [Abstract][Full Text] [Related]
5. Ankyrin-G coordinates intercalated disc signaling platform to regulate cardiac excitability in vivo.
Makara MA; Curran J; Little SC; Musa H; Polina I; Smith SA; Wright PJ; Unudurthi SD; Snyder J; Bennett V; Hund TJ; Mohler PJ
Circ Res; 2014 Nov; 115(11):929-38. PubMed ID: 25239140
[TBL] [Abstract][Full Text] [Related]
6. Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes.
Mohler PJ; Rivolta I; Napolitano C; LeMaillet G; Lambert S; Priori SG; Bennett V
Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17533-8. PubMed ID: 15579534
[TBL] [Abstract][Full Text] [Related]
7. Defining new insight into atypical arrhythmia: a computational model of ankyrin-B syndrome.
Wolf RM; Mitchell CC; Christensen MD; Mohler PJ; Hund TJ
Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1505-14. PubMed ID: 20729400
[TBL] [Abstract][Full Text] [Related]
8. Targeting and stability of Na/Ca exchanger 1 in cardiomyocytes requires direct interaction with the membrane adaptor ankyrin-B.
Cunha SR; Bhasin N; Mohler PJ
J Biol Chem; 2007 Feb; 282(7):4875-4883. PubMed ID: 17178715
[TBL] [Abstract][Full Text] [Related]
9. Ankyrin-B coordinates the Na/K ATPase, Na/Ca exchanger, and InsP3 receptor in a cardiac T-tubule/SR microdomain.
Mohler PJ; Davis JQ; Bennett V
PLoS Biol; 2005 Dec; 3(12):e423. PubMed ID: 16292983
[TBL] [Abstract][Full Text] [Related]
10. Cardiac ankyrins in health and disease.
Hashemi SM; Hund TJ; Mohler PJ
J Mol Cell Cardiol; 2009 Aug; 47(2):203-9. PubMed ID: 19394342
[TBL] [Abstract][Full Text] [Related]
11. Ankyrins and human disease: what the electrophysiologist should know.
Mohler PJ
J Cardiovasc Electrophysiol; 2006 Oct; 17(10):1153-9. PubMed ID: 16800854
[TBL] [Abstract][Full Text] [Related]
12. Novel Variant in the
Swayne LA; Murphy NP; Asuri S; Chen L; Xu X; McIntosh S; Wang C; Lancione PJ; Roberts JD; Kerr C; Sanatani S; Sherwin E; Kline CF; Zhang M; Mohler PJ; Arbour LT
Circ Cardiovasc Genet; 2017 Jan; 10(1):. PubMed ID: 28196901
[TBL] [Abstract][Full Text] [Related]
13. Atrial fibrillation and sinus node dysfunction in human ankyrin-B syndrome: a computational analysis.
Wolf RM; Glynn P; Hashemi S; Zarei K; Mitchell CC; Anderson ME; Mohler PJ; Hund TJ
Am J Physiol Heart Circ Physiol; 2013 May; 304(9):H1253-66. PubMed ID: 23436330
[TBL] [Abstract][Full Text] [Related]
14. Ankyrin-based targeting pathway regulates human sinoatrial node automaticity.
Hund TJ; Mohler PJ
Channels (Austin); 2008; 2(6):404-6. PubMed ID: 19098452
[TBL] [Abstract][Full Text] [Related]
15. Voltage-gated Nav channel targeting in the heart requires an ankyrin-G dependent cellular pathway.
Lowe JS; Palygin O; Bhasin N; Hund TJ; Boyden PA; Shibata E; Anderson ME; Mohler PJ
J Cell Biol; 2008 Jan; 180(1):173-86. PubMed ID: 18180363
[TBL] [Abstract][Full Text] [Related]
16. Being there: cellular targeting of voltage-gated sodium channels in the heart.
Bennett V; Healy J
J Cell Biol; 2008 Jan; 180(1):13-5. PubMed ID: 18180365
[TBL] [Abstract][Full Text] [Related]
17. Pleiotropic Ankyrins: Scaffolds for Ion Channels and Transporters.
Stevens SR; Rasband MN
Channels (Austin); 2022 Dec; 16(1):216-229. PubMed ID: 36082411
[TBL] [Abstract][Full Text] [Related]
18. Ankyrin-based cellular pathways for cardiac ion channel and transporter targeting and regulation.
Cunha SR; Mohler PJ
Semin Cell Dev Biol; 2011 Apr; 22(2):166-70. PubMed ID: 20934528
[TBL] [Abstract][Full Text] [Related]
19. Abnormal cardiac Na(+) channel properties and QT heart rate adaptation in neonatal ankyrin(B) knockout mice.
Chauhan VS; Tuvia S; Buhusi M; Bennett V; Grant AO
Circ Res; 2000 Mar; 86(4):441-7. PubMed ID: 10700449
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms and Alterations of Cardiac Ion Channels Leading to Disease: Role of Ankyrin-B in Cardiac Function.
Sucharski HC; Dudley EK; Keith CBR; El Refaey M; Koenig SN; Mohler PJ
Biomolecules; 2020 Jan; 10(2):. PubMed ID: 32023981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
